TNFα-induced necroptosis and autophagy via supression of the p38-NF-κB survival pathway in L929 cells

Journal of Pharmacological Sciences

Volumn 117, Issue 3, 2011, Pages 160-169

  Ye, Yuan Chao ^a   Yu, Lu ^a   Wang, Hong Ju ^a   Tashiro, Shin Ichi ^b   Onodera, Satoshi ^b   Ikejima, Takashi ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b SHOWA PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Autophagy; Necroptosis; Necrostatin 1; p38 nuclear factor kappa B (NF B) signaling pathway; Tumor necrosis factor alpha (TNF )

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; AUTOPHAGY; CELL DEATH; CELL STRAIN L 929; CONTROLLED STUDY; CYTOTOXICITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; NECROPTOSIS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

EID: 81455149975     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.11105FP     Document Type: Article

References (37)

1. Holler N, Zaru R, Micheau O, Thome M, Attinger A, Valitutti S, et al. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat Immunol. 2000;1:489-495.
2. Declercq W, Vanden Berghe T, Vandenabeele P. RIP kinases at the crossroads of cell death and survival. Cell. 2009;138:229-232.
3. Degterev A, Hitomi J, Germscheid M, Ch'en IL, Korkina O, Teng X, et al. Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat Chem Biol. 2008;4:313-321. (Pubitemid 351550892)
4. Kroemer G, Galluzzi L, Vandenabeele P, Abrams J, Alnemri ES, Baehrecke EH, et al. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ. 2009;16:3-11.
5. Peter ME. Programmed cell death: apoptosis meets necrosis. Nature. 2011;471:310-312.
6. Kaiser WJ, Upton JW, Livingston-Rosanoff D, Daley-Bauer LP, Caspsry T, Mocarski ES. RIP3 mediates the emvryonic lethality of caspase-8-deficient mice. Nature. 2011;471:368-372.
7. Oberst A, Dillon CP, Weinlich R, McCormick LL, Fitzgerald P, Pop C, et al. Catalytic activity of caspsed-8-FLIP(L) complex inhibits RIPK3-dependent necrosis. Nature. 2011;471:363-367.
8. Levine B, Yuan J. Autophagy in cell death: an innocent convict? J Clin Invest. 2005;115:2679-2688. (Pubitemid 41434392)
9. Martinet W, Agostinis P, Vanhoecke B, Dewaele M, De Meyer GR. Autophagy in disease: a double-edged sword with therapeutic potential. Clin Sci (Lond). 2009;116:697-712.
10. Lleo A, Invernizzi P, Selmi C, Coppel RL, Alpini G, Podda M, et al. Autophagy: highlighting a novel player in the autoimmunity scenario. J Autoimmun. 2007;29:61-68. (Pubitemid 47393611)
11. Biederbick A, Kern HF, Elsaesser HP. Monodansylcadaverine (MDC) is a specific in vivo marker for autophaic vacuoles. Eur J Cell Biol. 1995;66:3-14.
12. Yoshizumi M, Abe J, Tsuchiya K, Berk BC, Tamaki T. Stress and vascular responses: atheroprotective effect of laminar fluid stress in endothelial cells: possible role of mitogen-activated protein kinases. J Pharmacol Sci. 2003;91:172-176. (Pubitemid 36575572)
13. Wang X, Lin Y. Tumor necrosis factor and cancer, buddies or foes? Acta Pharmacol Sin. 2008;29:1275-1288.
14. Liu ZG, Han J. Cellular responses to tumor necrosis factor. Curr Issues Mol Biol. 2001;3:79-90. (Pubitemid 33061771)
15. Chen G, Goeddel DV. TNF-R1 signaling: a beautiful pathway. Science. 2002;296:1634-1635. (Pubitemid 34579145)
16. Wajant H, Pfizenmaier K, Scheurich P. Tumor necrosis factor signaling. Cell Death Differ. 2003;10:45-65. (Pubitemid 36511832)
17. Djavaheri-Mergny M, Codogno P. Autophagy joins the game to regulate NF-kappa B signaling pathways. Cell Res. 2007;17:576-577. (Pubitemid 47116352)
18. Ribble D, Goldstein NB, Norris DA, Shellman YG. A simple technique for quantifying apoptosis in 96-well plates. BMC Biotechnol. 2005;5:12.
19. Han W, Xie J, Li L, Liu Z, Hu X. Necrostatin-1 reverts shikonin-induced necroptosis to apoptosis. Apoptosis. 2009;14:674-686.
20. Cui Q, Tashiro S, Onodera S, Minami M, Ikwjima T. Oridonin induced autophagy in human cervical carcinoma HeLa cells through Ras, JNK, and p38 regulation. J Pharmacol Sci. 2007;105:317-325.
21. Kabeya Y, Mizushima N, Ueno T, Yamamoto A, Kirisako T, Noda T, et al. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J. 2000;19:5720-5728.
22. Degterev A, Huang Z, Boyce M, Li Y, Jagtap P, Mizushima N, et al. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol. 2005;1:112-119.
23. Bell BD, Leverrier S, Weist BM, Newton RH, Arechiga AF, Luhrs KA, et al. FADD and caspase-8 control the outcome of autophagic signaling in proliferating T cells. Proc Natl Acad Sci U S A. 2008;105:16677-16682.
24. Cauwels A, Janssen B, Waeytens A, Cuvelier C, Brouckaert P. Caspase inhibition causes hyperacute tumor necrosis factor-induced shock via oxidative stress and phospholipase A2. Nat Immunol. 2003;4:387-393. (Pubitemid 36432323)
25. Tait SW, Green DR. Caspase independent cell death: leaving the set without the final cut. Oncogene. 2008;27:6452-6461.
26. Hitomi J, Christofferson DE, Ng A, Yao J, Degterev A, Xavier RJ, et al. Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway. Cell. 2008;135:1311-1323.
27. Yu L, Alva A, Su H, Dutt P, Freundt E, Welsh S, et al. Regulation of an ATG7-beclin 1 program of autophagic cell death by caspase-8. Science. 2004;304:1500-1502. (Pubitemid 38720930)
28. Bermudez O, Pages G, Gimond C. The dual-specificity MAP kinase phosphatases: critical roles in development and cancer. Am J Physiol Cell Physio. 2010;299:C189-C202.
29. Chen SY, Chiu LY, Maa MC, Wang JS, Chien CL, Lin WW. zVAD-induced autophagic cell death requires c-Src-dependent ERK and JNK activation and reactive oxygen species generation. Autophagy. 2011;7:217-228.
30. Wu YT, Tan HL, Huang Q, Sun XJ, Zhu X, Shen HM. zVAD-induced necroptosis in L929 cells depends on autocrine production of TNFalpha mediated by the PKC-MAPKs-AP-1 pathway. Cell Death Differ. 2011;18:26-37.
31. Temkin V, Huang Q, Liu H, Osada H, Pope RM. Inhibition of ADP/ATP exchange in receptor-interacting protein-mediated necrosis. Mol Cell Biol. 2006;26:2215-2225. (Pubitemid 43346922)
32. Tamada S, Asai T, Kuwabara N, Iwai T, Uchida J, Teramoto K, et al. Molecular mechanisms and therapeutic strategies of chronic renal injury: the role of nuclear factor kappaB activation in the development of renal fibrosis. J Pharmacol Sci. 2006;100:17-21. (Pubitemid 43161609)
33. Scheidereit C. IkappaB kinase complexes: gateways to NF-kappaB activation and transcription. Oncogene. 2006;25:6685-6705. (Pubitemid 44657846)
34. Hill CS, Treisman R. Transcriptional regulation by extracellular signals: mechanisms and specificity. Cell. 1995;80:199-211.
35. Van Herreweghe F, Festjens N, Declercq W, Vandenabeele P. Tumor necrosis factor-mediated cell death: to break or to burst, that's the question. Cell Mol Life Sci. 2010;67:1567-1579.
36. Saha RN, Jana M, Pahan K. MAPK p38rRegulates transcriptional activity of NF-κB in primary human astrocytes via acetylation of p65. J Immunol. 2007;178:7101-7109.
37. Djavaheri-Mergny M, Amelotti M, Mathieu J, Besancon F, Bauvy C, Souquere S, et al. NF-kappaB activation represses tumor necrosis factor-alpha-induced autophagy. J Biol Chem. 2006;281:30373-30382. (Pubitemid 44582093)